West Pharmaceutical Services, Inc.'s Q2 results highlight growth driven by GLP-1 drugs and high-value products. Click for WST ...

West Pharmaceutical Services delivered a quarter that outperformed Wall Street’s expectations, reflecting renewed strength in ...

In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 22.9% in the afternoon session after the ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported in Q2 CY2025, with sales up 9.2% year on year to ...

West Pharmaceutical Services stock was soaring Thursday after the maker of injectable medicines reported better-than-expected ...

The S&P 500 gained 0.1% on Thursday, July 24, 2025, notching an all-time closing high for the fourth straight day following ...

The consensus price target hints at a 25.3% upside potential for West Pharmaceutical (WST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector.

West Pharmaceutical Services, Inc. (NYSE:WST) shares are surging Thursday after the injectable pharmaceutical packaging and ...

West Pharmaceutical Services’ operating margin of 26% over the last twelve-month period is better than 18% for Catalent. This compares with 17% and 6% figures seen in 2019, before the pandemic ...

The stock price of West Pharmaceutical Services, best known for injectable pharmaceutical packaging and delivery systems, has rallied around 78% over recent weeks (vs. about a 40% gain in the S&P ...